The company that uses synthetic biology to program mRNA and establish revolutionary therapies. Based on research at MIT and Kyoto University, building a proprietary mRNA programming language and provide a drug discovery pipeline and platform business targeting cancer and immune cells
Company name
Strand Therapeutics Inc.
Type of business
Medical(medical devices, drug discovery)
Representatives
Jacob Becraft
Establishing a company
December 2017
Investment announcement date
November 2024
Capitalist
Jun Hayashi
HP
https://www.strandtx.com/Phasing
Middle to Growth
